Neuroprotective agents in brain injury: A partial failure?

George E. Barreto, Janneth Gonzalez, Francisco Capani, Ludis Morales

Research output: Contribution to journalShort surveypeer-review

Abstract

Brain injury leads to inflammation, stress, and cell death. Neurons are more susceptible to injury than astrocytes, as they have limited antioxidant capacity, and rely heavily on their metabolic coupling with astrocytes to combat oxidative stress. Both normally and after brain injury, astrocytes support neurons by providing antioxidant protection, substrates for neuronal metabolism, and glutamate clearance. Although astrocytes are generally more resilient than neurons after injury, severe damage also results in astrocyte dysfunction, leading to increased neuronal death. This mini review provides a very insightful and brief overview on a few examples of promising neuroprotective compounds targeting astrocyte function, with specific attention on how these treatments alter astrocyte response or viability, and how this may be critical for neuronal survival following brain injury.

Original languageEnglish
Pages (from-to)223-226
Number of pages4
JournalInternational Journal of Neuroscience
Volume122
Issue number5
DOIs
Publication statusPublished - May 2012
Externally publishedYes

Keywords

  • astrocytes
  • brain injury
  • clinical trials
  • neurons
  • neuroprotection

Fingerprint

Dive into the research topics of 'Neuroprotective agents in brain injury: A partial failure?'. Together they form a unique fingerprint.

Cite this